Facebook
Google+
LinkedIn
Educational Events & Programs
Enroll Now!
Tuesday, October 6, 2020
Virtual Webinar
12:30 – 3:30 PM ET
OVERVIEW
During this interactive online program, pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Through this pharmaceutical and biotech training program, participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care ecosystem. Pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.
Please check back often for additional updates regarding this program. If you have any questions, please contact Elyse Desjardins, Senior Manager, Business Development.
MODERATOR
Clifford Goodman, PhD
Senior Vice President
The Lewin Group
CURRICULUM*
12:30 – 12:35 PM |
Welcome
Elyse N. Desjardins, MBA
Senior Manager, Business Development
National Comprehensive Cancer Network |
12:35 – 1:55 PM |
Module I: Oncology Medical Home: Perspectives on Evolution, Impact & Future State
Moderator
Clifford Goodman, PhD
Senior Vice President
The Lewin Group
Russell J. Hoverman, MD, PhD
Vice President, Quality Programs, Medical Director, Manage Care
Texas Oncology
Medical Director of Managed Care
US Oncology Network
Ron Kline, MD, FAAP
Chief Medical Officer | Healthcare and Insurance
US Office of Personnel Management
Formerly, Clinical Lead for CMS' Oncology Care Model
Michael Kolodziej, MD
Vice President and Chief Innovation Officer
ADVI
Brady Luby, MS
Manager, Contracting & Payor Relations
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Barbara McAneny, MD, FASCO, MACP
Chief Executive Officer & Immediate Past-President, American Medical Association
New Mexico Oncology Hematology Consultants, Ltd
Maya Said, Sc.D.
Founder & Chief Executive Officer
Outcomes4Me
|
| 1:55 – 3:25 PM |
Module II: Pathways: A View Across Developers and Stakeholders
Alan Balch, PhD
Chief Executive Officer
Patient Advocate Foundation
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network
Andrew Hertler, MD, FACP
Chief Medical Officer
New Century Health
Russell J. Hoverman, MD, PhD
Vice President, Quality Programs, Medical Director, Managed Care
Texas Oncology
Medical Director of Managed Care
US Oncology Network
Zachary Lorinc
Senior Director of Operations
Elsevier, Clinical Path |
| 3:25 – 3:30 PM |
Closing Remarks
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network |
*Curriculum subject to change.
INTENDED AUDIENCE
Professionals from advocacy, marketing, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.
NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.
Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.